Impact of size, histology, and gender on stage IA non-small cell lung cancer.
作者： Andrea Campione , Tommaso Ligabue , Luca Luzzi , Claudia Ghiribelli , Piero Paladini
DOI: 10.1177/021849230401200214
关键词:
摘要: The aim of this study was to assess which prognostic factors could influence survival in surgically treated stage IA non-small cell lung cancer. records 224 consecutive patients with pathological after radical surgery were reviewed retrospectively. Overall 1, 3 and 5-year rates 89%, 76%, 66%. Nearly half the deaths unrelated original There no difference attributable preoperative pulmonary function, age at operation, or extent resection. However, limited resections had a higher rate local recurrence. Survival better smaller size tumor (= 2 cm), female sex, cases bronchoalveolar adenocarcinoma.
core.ac.uk
unifi.it
sagepub.com
sci-hub.se 参考文章(19)
Morikawa T, Okushiba S, Kondo S, Kaji M, Yanagi S, Sugiura H, Katoh H, Tumor size does not have prognostic significance in stage Ia NSCLC. Anticancer Research. ,vol. 20, pp. 1155- 1158 ,(2000)
William H. Warren, L. Penfield Faber, Segmentectomy versus lobectomy in patients with stage I pulmonary carcinoma: Five-year survival and patterns of intrathoracic recurrence The Journal of Thoracic and Cardiovascular Surgery. ,vol. 107, pp. 1087- 1094 ,(1994) , 10.1016/S0022-5223(12)70385-9
H M Golomb, R R Blough, P C Hoffman, C Skosey, M K Ferguson, A G Little, D B Skinner, T R DeMeester, Modified stage I (T1N0M0, T2N0M0), nonsmall cell lung cancer: treatment results, recurrence patterns, and adjuvant immunotherapy. Surgery. ,vol. 100, pp. 621- 628 ,(1986)
Christos Alexiou, C.V. Patrick Onyeaka, David Beggs, Ruchan Akar, Lynda Beggs, Fayek D. Salama, John P. Duffy, W. Ellis Morgan, Do women live longer following lung resection for carcinoma? European Journal of Cardio-Thoracic Surgery. ,vol. 21, pp. 319- 325 ,(2002) , 10.1016/S1010-7940(01)01114-9
Clifton F. Mountain, Revisions in the International System for Staging Lung Cancer Chest. ,vol. 111, pp. 1710- 1717 ,(1997) , 10.1378/CHEST.111.6.1710
R. Feld, L. Rubinstein, P. A. Thomas, The Lung Cancer Study Group, Adjuvant Chemotherapy With Cyclophosphamide, Doxorubicin, and Cisplatin in Patients With Completely Resected Stage I Non-Small-Cell Lung Cancer Journal of the National Cancer Institute. ,vol. 85, pp. 299- 306 ,(1993) , 10.1093/JNCI/85.4.299
Edward F. Patz, Santiago Rossi, David H. Harpole, James E. Herndon, Philip C. Goodman, Correlation of Tumor Size and Survival in Patients With Stage IA Non-small Cell Lung Cancer Chest. ,vol. 117, pp. 1568- 1571 ,(2000) , 10.1378/CHEST.117.6.1568
Yukinori Sakao, Toru Sakuragi, Masafumi Natsuaki, Tsuyoshi Itoh, Clinicopathological analysis of prognostic factors in clinical IA peripheral adenocarcinoma of the lung. The Annals of Thoracic Surgery. ,vol. 75, pp. 1113- 1117 ,(2003) , 10.1016/S0003-4975(02)04718-5
Steven C. Immerman, Robert M. Vanecko, Willard A. Fry, Louis R. Head, Thomas W. Shields, Site of Recurrence in Patients with Stages I and II Carcinoma of the Lung Resected for Cure The Annals of Thoracic Surgery. ,vol. 32, pp. 23- 27 ,(1981) , 10.1016/S0003-4975(10)61368-9
Jonathan C. Nesbitt, Joe B. Putnam, Garrett L. Walsh, Jack A. Roth, Clifton F. Mountain, Survival in early-stage non-small cell lung cancer The Annals of Thoracic Surgery. ,vol. 60, pp. 466- 472 ,(1995) , 10.1016/0003-4975(95)00169-L